After Reporting Q2 Earnings, is Teladoc Health a Buy?

This post was originally published on this site

Although the company reported strong revenue growth in the quarter, its total expenses and losses increased significantly year-over-year.

While the launch of its “myStrength Complete” personalized mental health service and strategic agreement with HCSC to offer its suite of whole-person chronic care solutions could strengthen its position in the telehealth industry, its bleak growth prospects and slim profit margin could continue concerning investors. In addition, in a highly competitive environment, the stock may not be able to sustain its high valuation.

Continue reading on StockNews